[go: up one dir, main page]

MX2018000528A - Dispositivo para la deteccion de proteinas mal plegadas y metodos de uso del mismo. - Google Patents

Dispositivo para la deteccion de proteinas mal plegadas y metodos de uso del mismo.

Info

Publication number
MX2018000528A
MX2018000528A MX2018000528A MX2018000528A MX2018000528A MX 2018000528 A MX2018000528 A MX 2018000528A MX 2018000528 A MX2018000528 A MX 2018000528A MX 2018000528 A MX2018000528 A MX 2018000528A MX 2018000528 A MX2018000528 A MX 2018000528A
Authority
MX
Mexico
Prior art keywords
methods
misfolded proteins
proteins
disorders
use therof
Prior art date
Application number
MX2018000528A
Other languages
English (en)
Other versions
MX395376B (es
Inventor
l davis Wendy
Levenson Daniel
Original Assignee
Gestvision Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gestvision Inc filed Critical Gestvision Inc
Publication of MX2018000528A publication Critical patent/MX2018000528A/es
Publication of MX395376B publication Critical patent/MX395376B/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2835—Movement disorders, e.g. Parkinson, Huntington, Tourette

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se refiere a dispositivos de diagnóstico así como a métodos de uso de estos dispositivos para detectar las proteínas de interés asociadas con enfermedades o trastornos en mamíferos; en particular, las proteínas de interés pueden ser proteínas mal plegadas asociadas con ciertos trastornos de proteínas mal plegadas en mamíferos que incluyen esos mamíferos que se sospecha que tienen o que están en riesgo de tener esos trastornos.
MX2018000528A 2015-07-15 2016-07-15 Dispositivo para la deteccion de proteinas mal plegadas y metodos de uso del mismo. MX395376B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562192962P 2015-07-15 2015-07-15
PCT/US2016/042426 WO2017011727A1 (en) 2015-07-15 2016-07-15 Device for detecting misfolded proteins and methods of use therof

Publications (2)

Publication Number Publication Date
MX2018000528A true MX2018000528A (es) 2018-08-21
MX395376B MX395376B (es) 2025-03-25

Family

ID=57758210

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2018000528A MX395376B (es) 2015-07-15 2016-07-15 Dispositivo para la deteccion de proteinas mal plegadas y metodos de uso del mismo.
MX2022010954A MX2022010954A (es) 2015-07-15 2018-01-12 Dispositivo para la deteccion de proteinas mal plegadas y metodos de uso del mismo.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2022010954A MX2022010954A (es) 2015-07-15 2018-01-12 Dispositivo para la deteccion de proteinas mal plegadas y metodos de uso del mismo.

Country Status (14)

Country Link
US (5) US10564153B2 (es)
EP (2) EP3322985B1 (es)
JP (3) JP6885608B2 (es)
CN (2) CN111965343B (es)
AR (1) AR105379A1 (es)
AU (2) AU2016293547C1 (es)
CA (1) CA2989444A1 (es)
DK (1) DK3322985T3 (es)
ES (1) ES2903034T3 (es)
MX (2) MX395376B (es)
PL (1) PL3322985T3 (es)
PT (1) PT3322985T (es)
TW (3) TWI856560B (es)
WO (1) WO2017011727A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11186557B2 (en) * 2015-09-29 2021-11-30 Hamamatsu Photonics K.K. Method for purifying pure thioflavin T, method for producing pure thioflavin T, composition including thioflavin T, and amyloid detection method
TWI698641B (zh) * 2017-12-28 2020-07-11 大陸商浙江數問生物技術有限公司 一種檢測錯誤折疊蛋白質的裝置、試劑盒和方法
EP3734282A4 (en) * 2017-12-28 2021-10-13 Shuwen Biotech Co., Ltd. DEVICE, REAGENT KIT AND METHOD FOR DETECTION OF MISFOLDED PROTEIN
US12436155B2 (en) 2020-04-16 2025-10-07 Kalia Health, Inc. Preeclampsia screening device and methods measuring activin and/or inhibin A
US20230131712A1 (en) * 2020-04-30 2023-04-27 Daxor Corp. Blood volume measurement with fluorescent dye
AU2021384645A1 (en) 2020-11-21 2023-07-06 Shuwen Biotech Co., Ltd. Apparatus and method for detecting misfolded protein in biological sample
WO2022193028A1 (en) * 2021-03-19 2022-09-22 Kenota Inc. Assay membrane test region localization

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2684488A (en) * 1988-06-27 1990-01-04 Carter-Wallace, Inc. Test device and method for colored particle immunoassay
US5252496A (en) * 1989-12-18 1993-10-12 Princeton Biomeditech Corporation Carbon black immunochemical label
US5451504A (en) * 1991-07-29 1995-09-19 Serex, Inc. Method and device for detecting the presence of analyte in a sample
US5804452A (en) * 1995-04-27 1998-09-08 Quidel Corporation One step urine creatinine assays
US6800488B2 (en) * 2000-12-13 2004-10-05 Lifescan, Inc. Methods of manufacturing reagent test strips
GB2391068A (en) 2002-07-18 2004-01-28 Sensor Tech Ltd A lateral flow through device comprising an electrochemical sesor
WO2005001444A1 (en) * 2003-06-03 2005-01-06 Bayer Healthcare Llc. Verification device and method for optical inspection machine
EP1651964A2 (en) * 2003-07-31 2006-05-03 Hadasit Medical Research Services & Development Ltd. Methods and kits for the detection of prion diseases
JP4624364B2 (ja) * 2003-12-12 2011-02-02 アレル・スウイツツアーランド・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング アッセイ
US7763454B2 (en) 2004-07-09 2010-07-27 Church & Dwight Co., Inc. Electronic analyte assaying device
MX2007003522A (es) * 2004-09-24 2007-06-11 Beth Israel Hospital Complicaciones del embarazo.
EP1946121A2 (en) 2005-10-27 2008-07-23 Yale University, Inc. Urinary proteomic biomarker patterns in preeclampsia
TW200801190A (en) * 2005-11-21 2008-01-01 Trustees Of The University Of Alabama For And On Behalf Of The University Of Board Of Regulators of protein misfolding and aggregation and methods of using the same
US8343439B2 (en) * 2006-06-20 2013-01-01 Amic Ab Assay device
WO2009003177A1 (en) * 2007-06-27 2008-12-31 Inbios International, Inc. Lateral flow assay system and methods for its use
US9229009B2 (en) * 2008-10-31 2016-01-05 Yale University Methods and kits for detecting misfolded proteins
SG175699A1 (en) * 2009-03-19 2011-12-29 Kaneka Corp Method, kit and device for detecting nucleic acid
TWM384314U (en) * 2010-01-29 2010-07-11 Nat Univ Chin Yi Technology Protein folding calculation device
JP2012068064A (ja) * 2010-09-22 2012-04-05 Pilot Ink Co Ltd 液体試料検査具及び液体検査具の採液部構造
DE102011003944A1 (de) * 2011-02-10 2012-08-16 Oxprotect Gmbh Detektion und Entfernung von missgefalteten Proteinen/Peptiden
EP2602620A1 (en) 2011-12-07 2013-06-12 Nxp B.V. An electronic lateral flow test arrangement and method
CA2859295A1 (en) * 2011-12-15 2013-06-20 Pronota N.V. Biomarkers and parameters for preeclampsia
US10670610B2 (en) * 2012-06-15 2020-06-02 Wayne State University Biomarker test for prediction or early detection of preeclampsia and/or HELLP syndrome
JP2016501247A (ja) * 2012-12-07 2016-01-18 バイオジェン インターナショナル ニューロサイエンス ゲーエムベーハー 抗Ａβ抗体を使用して脳アミロイド斑を減少させる方法
WO2014124396A1 (en) * 2013-02-08 2014-08-14 University Of Iowa Research Foundation Therapeutic strategies for the treatment of preeclampsia
JP6182027B2 (ja) * 2013-09-10 2017-08-16 デンカ生研株式会社 Ｂ型インフルエンザウイルスの測定方法
DK3129779T3 (da) 2014-04-10 2020-09-07 Univ Yale Fremgangsmåder og sammensætninger til påvisning af fejlfoldede proteiner
TWM494304U (zh) * 2014-10-31 2015-01-21 Anatech Co Ltd 非酵素型糖化血色素檢測裝置

Also Published As

Publication number Publication date
TW201716778A (zh) 2017-05-16
CN108291905A (zh) 2018-07-17
PL3322985T3 (pl) 2022-02-21
EP4036574A1 (en) 2022-08-03
US20200141932A1 (en) 2020-05-07
JP7648188B2 (ja) 2025-03-18
US20250306019A1 (en) 2025-10-02
AR105379A1 (es) 2017-09-27
CN111965343B (zh) 2023-05-09
CA2989444A1 (en) 2017-01-19
US20170016891A1 (en) 2017-01-19
TW202208853A (zh) 2022-03-01
DK3322985T3 (da) 2022-01-17
ES2903034T3 (es) 2022-03-30
US20210318299A1 (en) 2021-10-14
BR112017028627A2 (pt) 2018-09-04
HK1247282A1 (zh) 2018-09-21
JP6885608B2 (ja) 2021-06-16
PT3322985T (pt) 2022-01-13
TW202331255A (zh) 2023-08-01
JP2023027284A (ja) 2023-03-01
WO2017011727A1 (en) 2017-01-19
US20230251251A1 (en) 2023-08-10
EP3322985A1 (en) 2018-05-23
TWI744239B (zh) 2021-11-01
TWI800009B (zh) 2023-04-21
AU2016293547B2 (en) 2023-03-09
AU2023201820A1 (en) 2023-04-27
US11073516B2 (en) 2021-07-27
AU2016293547C1 (en) 2023-06-29
CN111965343A (zh) 2020-11-20
MX395376B (es) 2025-03-25
TWI856560B (zh) 2024-09-21
CN108291905B (zh) 2020-09-11
MX2022010954A (es) 2022-10-07
JP2018527587A (ja) 2018-09-20
JP2021073434A (ja) 2021-05-13
US10564153B2 (en) 2020-02-18
AU2016293547A1 (en) 2018-01-18
EP3322985A4 (en) 2019-01-09
EP3322985B1 (en) 2021-10-13

Similar Documents

Publication Publication Date Title
MX2018000528A (es) Dispositivo para la deteccion de proteinas mal plegadas y metodos de uso del mismo.
EA201692529A1 (ru) Способы и композиции для лечения расстройств с использованием фоллистатиновых полипептидов
EA201791029A1 (ru) Антитела против интерлейкина-33 и их применение
EA201692477A1 (ru) Композиции и способы применения для лечения метаболических расстройств
MX373580B (es) Composiciones y métodos de limpieza.
EA201690969A1 (ru) Способы и композиции для лечения связанных со старением состояний
UA117470C2 (uk) Заміщені ксантини та способи їх застосування
AR090973A1 (es) Anticuerpos utiles para el diagnostico del cancer
EA201890747A1 (ru) Способы лечения воспалительных заболеваний
WO2015031808A3 (en) Diagnostic methods and compositions for treatment of glioblastoma
NZ720769A (en) Anti-siglec-8 antibodies and methods of use thereof
IN2014DN05885A (es)
PT3200582T (pt) Composições, kits e métodos para induzir citorresistência adquirida com utilização de indutores de proteínas de stress
MX2023012628A (es) Metodos y composiciones para deteccion y diagnostico de enfermedades renales y enfermedades periodontales.
MX2016003002A (es) Metodos para determinar la respuesta a la terapia.
IL255612A (en) Methods for diagnosing and assessing treatment for cushing's syndrome
CL2016000939A1 (es) Compuestos derivados de pirimidina con actividad inhibidora de syk uso en el tratamiento de una condición inmune, enfermedades inflamatorias, trastornos alérgicos, lupus eritomatosos, epoc, bronquitis, rinitis alérgica, asma, entre otras composición farmacéutica que los comprende.
IL254641A0 (en) Methods and compositions to inhibit symptoms associated with veisalgia
WO2015022077A8 (en) Novel anti-fc-gamma receptor iib antibodies and uses thereof
MX2015009153A (es) Uso de agonistas del receptor nicotinico de acetilcolina alfa 7.
MX388832B (es) Deteccion especifica de isoformas de clusterina.
PH12016501434A1 (en) Compositions for use in the treatment of allergic conditions
WO2015091902A3 (en) Determination of platelet-mirnas in alzheimer's disease
MX2019014090A (es) Métodos para el tratamiento de la reservoritis crónica.
WO2015134631A3 (en) Compositions and methods for identifying b cell malignancies responsive to b cell depleting therapy